A partnership that will push forward the medical sector
CARMAT and AddUP join forces to support the industrial development of the CARMAT’s heart. Both companies aim to increase CARMAT’s production capacity in order to manufacture on a large scale.
It all begins with…
CARMAT which designs and develops an advanced artificial heart project, which would be a solution and a therapeutic alternative for patients suffering from end-stage biventricular heart failure.
As for AddUp, the company is the joint venture of Michelin and Fives groups specialized in 3D printing.
Thanks to AddUp’s 3D printing technology, CARMAT’s surgeons will improve the artificial heart. Indeed, they will be able to optimize anatomical interfaces leading to enhanced anatomical compatibility and surgical comfort on the one hand; on the other hand, to reduce a great number of components, therefore better secure the device’s assembly.
Vincent Ferreiro, CEO and Chairman of AddUp, comments: “As pioneers in the development of industrial 3D printing solutions, we are delighted to have the opportunity to associate our unique additive manufacturing technology with a medical project as innovative as the CARMAT one. We possess a know-how in providing support to our partners from the feasibility stage to the industrialization of concept ideas. We are very enthusiastic about the ability to apply it to the medical field for the first time.”
Stéphane Piat, CEO of CARMAT, adds: “The CARMAT project has been, since the beginning, a perfect example of cooperation between the industrial and medical fields. The partnership agreement signed today with AddUp is an additional proof and will enable us – alongside our ongoing clinical development – to anticipate longer-term evolutions in our industrial and technical needs. With a partner as prestigious as AddUp, I am convinced in our ability to accelerate our industrialization and secure our project.”
For further information about 3D Printing, follow us on our social networks and subscribe to our newsletter!